So far, the vaccine roll out in the United States has been underwhelming. States are scrambling to get doses out to patients before they expire. We won’t be behind schedule on vaccine distribution forever, but to make matters worse, a more infectious variant of COVID-19 has increased the urgency.
Guest: Apoorva Mandavilli is a health and science reporter with the New York Times.
Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.
Hosted on Acast. See acast.com/privacy for more information.
